Board approves 1-for-10 reverse stock split for CLGN
Collplant Biotechnologies board of directors approved a 1-for-10 reverse stock split for CLGN.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.